Positron emission tomography (PET) has been approved for the diagnosis and staging of gynecologic malignancies for several years now. This issue reviews the imaging of cervical, uterine, and endometrial cancers. There is also an articles on the uses of PET/CT for imaging normal and abnormal anatomy, as well as gynecologic imaging using other modalities. Lastly this issue contains a review of newer radionuclide tracers currently in development.
By Ora Israel, Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel